The identity of the Cu(i) binding ligands at Met-X3-Met site of AcαS and its role into the affinity and structural properties of the interaction were elucidated by NMR spectroscopy. We provide evidence that the source of ligands for Cu(i) binding to the Met-X3-Met site comes from the N-terminal acetyl group and the Met-1, Asp-2 and Met-5 residues. From the study of site-directed mutants and synthetic peptide models of αS we demonstrated the critical role played by Met-1 and Met-5 residues on the binding affinity of the Cu(i) complex, acting as the main metal anchoring residues. While having a more modest impact in the affinity features of Cu(i) binding, as compared to the Met residues, the N-terminal acetyl group and Asp-2 are important in ...
Amyloid aggregation of α-synuclein (AS) has been linked to the pathological effects associated with ...
Alterations in the levels of copper in brain tissue and formation of α-synuclein (αS)-copper complex...
The aggregation of alpha-synuclein (alpha S) is a critical step in the etiology of Parkinson's disea...
The aggregation of alpha-synuclein (AS) is a critical step in the etiology of Parkinson's disease (P...
The aggregation of alpha-synuclein (AS) is a critical step in the etiology of Parkinson's disease (P...
The aggregation of alpha-synuclein (AS) is a critical step in the etiology of Parkinson's disease (P...
The amyloid aggregation of alpha-synuclein (AS) has been linked to the pathological effects associat...
Amyloid aggregation of a-synuclein (AS) has been linked to the pathological effects associated with ...
Alterations in the levels of copper in brain tissue and formation of α-synuclein (αS)-copper complex...
Amyloid aggregation of a-synuclein (AS) has been linked to the pathological effects associated with ...
Alterations in the levels of copper in brain tissue and formation of α-synuclein (αS)-copper complex...
Abstract: The aggregation of R-synuclein (AS) is selectively enhanced by copper in vitro, and the in...
Amyloid aggregation of α-synuclein (AS) is one of the hallmarks of Parkinson’s disease. The interact...
Alterations in the levels of copper in brain tissue and formation of α-synuclein (αS)-copper complex...
The aggregation of α -synuclein (AS) is characteristic of Parkinson’s disease and other neurodegener...
Amyloid aggregation of α-synuclein (AS) has been linked to the pathological effects associated with ...
Alterations in the levels of copper in brain tissue and formation of α-synuclein (αS)-copper complex...
The aggregation of alpha-synuclein (alpha S) is a critical step in the etiology of Parkinson's disea...
The aggregation of alpha-synuclein (AS) is a critical step in the etiology of Parkinson's disease (P...
The aggregation of alpha-synuclein (AS) is a critical step in the etiology of Parkinson's disease (P...
The aggregation of alpha-synuclein (AS) is a critical step in the etiology of Parkinson's disease (P...
The amyloid aggregation of alpha-synuclein (AS) has been linked to the pathological effects associat...
Amyloid aggregation of a-synuclein (AS) has been linked to the pathological effects associated with ...
Alterations in the levels of copper in brain tissue and formation of α-synuclein (αS)-copper complex...
Amyloid aggregation of a-synuclein (AS) has been linked to the pathological effects associated with ...
Alterations in the levels of copper in brain tissue and formation of α-synuclein (αS)-copper complex...
Abstract: The aggregation of R-synuclein (AS) is selectively enhanced by copper in vitro, and the in...
Amyloid aggregation of α-synuclein (AS) is one of the hallmarks of Parkinson’s disease. The interact...
Alterations in the levels of copper in brain tissue and formation of α-synuclein (αS)-copper complex...
The aggregation of α -synuclein (AS) is characteristic of Parkinson’s disease and other neurodegener...
Amyloid aggregation of α-synuclein (AS) has been linked to the pathological effects associated with ...
Alterations in the levels of copper in brain tissue and formation of α-synuclein (αS)-copper complex...
The aggregation of alpha-synuclein (alpha S) is a critical step in the etiology of Parkinson's disea...